VI
ACAD icon

Vestcor Inc’s Acadia Pharmaceuticals ACAD Stock Holding History

Vestcor Inc’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$503K Hold
22,601
– – 0.01% 723
2025
Q4 		$604K Hold
22,601
– – 0.02% 647
2025
Q3 		$482K Buy
+22,601
New +$535K 0.01% 726

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vestcor Inc's ACAD Position: Q1 2026 in Review

Vestcor Inc held its Acadia Pharmaceuticals (ACAD) position steady in Q1 2026 at 22,601 shares worth $503K. The position accounts for 0.01% of the portfolio, ranked #723.

Vestcor Inc first reported a position in ACAD in Q3 2025 and has held it in 3 quarters since. The position peaked at $604K in Q4 2025. 340 funds tracked by Wall St. Rank hold ACAD as of Q1 2026.

  • Vestcor Inc held 22,601 shares of Acadia Pharmaceuticals worth $503K as of Q1 2026.
  • Vestcor Inc left its Acadia Pharmaceuticals share count unchanged in Q1 2026.
  • Acadia Pharmaceuticals made up 0.01% of Vestcor Inc's portfolio in Q1 2026, its #723 holding.
  • Vestcor Inc first reported a position in Acadia Pharmaceuticals in Q3 2025 and has held it in 3 quarters since.
  • Vestcor Inc's Acadia Pharmaceuticals position peaked at $604K in Q4 2025.
  • 340 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q1 2026.

Based on Vestcor Inc's 13F filing for Q1 2026, filed 12 May 2026.